Cronos Group (CRON) Financials

$2.09 +0.02 (+0.97%)

As of 05/20/2025 04:00 PM Eastern

Annual Income Statements for Cronos Group

This table shows Cronos Group's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Income / (Loss) Attributable to Common Shareholders	41	-74	-169
Consolidated Net Income / (Loss)	40	-75	-169
Net Income / (Loss) Continuing Operations	40	-70	-155
Total Pre-Tax Income	37	-74	-121
Total Operating Income	-77	-85	-111
Total Gross Profit	25	12	15
Total Revenue	118	87	87
Operating Revenue	162	120	109
Other Revenue	-44	-33	-23
Total Cost of Revenue	92	75	71
Operating Cost of Revenue	92	75	71
Total Operating Expenses	102	97	127
Selling, General & Admin Expense	47	49	68
Marketing Expense	22	23	18
Research & Development Expense	4.23	5.84	13
Depreciation Expense	3.70	5.04	5.97
Other Operating Expenses / (Income)	8.70	8.76	15
Impairment Charge	16	3.37	3.49
Restructuring Charge	0.63	1.52	3.55
Total Other Income / (Expense), net	113	11	-9.58
Interest & Investment Income	87	53	26
Other Income / (Expense), net	26	-42	-35
Income Tax Expense	-3.44	-3.23	34
Net Income / (Loss) Discontinued Operations	0.00	-4.11	-14
Net Income / (Loss) Attributable to Noncontrolling Interest	-1.06	-0.59	0.00
Basic Earnings per Share	$0.11	($0.19)	($0.45)
Weighted Average Basic Shares Outstanding	382.53M	381.30M	380.58M
Diluted Earnings per Share	$0.11	($0.19)	($0.45)
Weighted Average Diluted Shares Outstanding	382.53M	381.30M	380.58M
Weighted Average Basic & Diluted Shares Outstanding	382.53M	381.30M	380.58M

This table shows Cronos Group's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	6.12	44	8.35	-8.76	-2.24	-45	-1.64	-8.36	-19	-79	-37
Consolidated Net Income / (Loss)	7.72	44	7.32	-8.76	-2.48	-45	-1.77	-8.50	-19	-79	-37
Net Income / (Loss) Continuing Operations	7.72	44	7.32	-8.76	-2.48	-45	-1.59	-5.66	-18	-72	-33
Total Pre-Tax Income	7.27	46	4.62	-11	-3.04	-46	-2.84	-5.84	-19	-40	-31
Total Operating Income	-4.07	-11	-34	-16	-16	-22	-22	-21	-21	-23	-27
Total Gross Profit	14	11	3.61	6.30	4.48	1.91	3.97	3.10	2.93	1.04	3.14
Total Revenue	32	18	47	28	25	24	25	19	19	20	20
Operating Revenue	42	41	47	39	35	34	34	26	27	27	26
Other Revenue	-9.64	-	-	-11	-10	-10	-9.10	-6.78	-7.06	-7.03	-5.66
Total Cost of Revenue	19	7.16	43	21	21	22	21	16	17	19	17
Operating Cost of Revenue	19	7.16	43	21	21	22	21	16	17	19	17
Total Operating Expenses	18	22	37	22	20	24	26	24	24	24	30
Selling, General & Admin Expense	9.31	12	13	13	8.91	9.80	14	13	12	13	16
Marketing Expense	4.57	6.41	5.53	4.33	5.33	6.37	5.30	5.30	5.74	3.60	5.25
Research & Development Expense	0.79	1.03	1.24	0.96	1.00	1.45	1.25	1.11	2.04	2.36	2.54
Depreciation Expense	0.50	0.46	1.10	1.02	1.12	0.53	1.46	1.53	1.53	1.57	1.70
Other Operating Expenses / (Income)	2.09	2.19	2.26	2.24	2.02	1.93	1.96	2.33	2.54	4.49	4.25
Impairment Charge	0.00	-	14	0.00	1.97	3.37	0.00	0.00	0.00	-	0.00
Restructuring Charge	0.56	-	0.00	0.55	0.08	0.10	1.42	0.00	0.00	-0.90	0.39
Total Other Income / (Expense), net	11	57	38	4.63	13	-24	19	15	1.30	-17	-3.65
Interest & Investment Income	9.67	12	45	14	16	15	14	13	11	8.52	6.09
Other Income / (Expense), net	1.68	45	-6.66	-9.74	-2.79	-39	4.50	2.04	-9.38	-26	-9.74
Income Tax Expense	-0.46	2.00	-2.71	-2.17	-0.56	-0.36	-1.25	-0.18	-1.44	32	2.12
Net Income / (Loss) Attributable to Noncontrolling Interest	1.60	0.21	-1.03	-0.00	-0.24	-0.24	-0.13	-0.14	-0.09	0.03	0.11
Basic Earnings per Share	$0.02	$0.12	$0.02	($0.02)	($0.01)	($0.12)	$0.00	($0.02)	($0.05)	-	($0.10)
Weighted Average Basic Shares Outstanding	385.42M	382.53M	382.29M	382.28M	382.01M	381.30M	381.11M	381.09M	380.82M	380.58M	378.47M
Diluted Earnings per Share	$0.02	$0.12	$0.02	($0.02)	($0.01)	($0.12)	$0.00	($0.02)	($0.05)	-	($0.10)
Weighted Average Diluted Shares Outstanding	385.42M	382.53M	382.29M	382.28M	382.01M	381.30M	381.11M	381.09M	380.82M	380.58M	378.47M
Weighted Average Basic & Diluted Shares Outstanding	385.42M	382.53M	382.29M	382.28M	382.01M	381.30M	381.11M	381.09M	380.82M	380.58M	378.47M

This table details how cash moves in and out of Cronos Group's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Change in Cash & Equivalents	190	-95	-122
Net Cash From Operating Activities	19	-43	-89
Net Cash From Continuing Operating Activities	19	-43	-89
Net Income / (Loss) Continuing Operations	40	-75	-169
Consolidated Net Income / (Loss)	40	-75	-169
Depreciation Expense	9.34	8.11	13
Non-Cash Adjustments To Reconcile Net Income	-30	50	51
Changes in Operating Assets and Liabilities, net	-0.31	-26	16
Net Cash From Investing Activities	175	-59	-1.84
Net Cash From Continuing Investing Activities	175	-59	-1.84
Purchase of Property, Plant & Equipment	-12	-2.51	-3.45
Acquisitions	-0.74	-0.92	-1.58
Purchase of Investments	0.00	-608	-271
Divestitures	5.99	0.00	0.00
Sale and/or Maturity of Investments	186	534	269
Other Investing Activities, net	-3.51	18	5.70
Net Cash From Financing Activities	-1.23	-1.03	-2.90
Net Cash From Continuing Financing Activities	-1.23	-1.03	-2.90
Repayment of Debt	0.00	0.00	-0.07
Other Financing Activities, net	-1.23	-1.03	-2.83
Effect of Exchange Rate Changes	-3.25	8.01	-29
Cash Interest Paid	0.00	0.00	0.00
Cash Interest Received	48	37	16
Cash Income Taxes Paid	0.65	33	0.18

This table details how cash moves in and out of Cronos Group's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-61	-3.23	14	-6.93	186	98	162	-4.24	-351	131	-156
Net Cash From Operating Activities	-2.10	7.72	12	1.74	-2.20	17	-0.18	-12	-48	-24	-13
Net Cash From Continuing Operating Activities	-2.10	7.72	12	1.74	-2.20	17	-0.18	-12	-48	-24	-13
Net Income / (Loss) Continuing Operations	7.72	44	7.32	-8.76	-2.48	-45	-1.77	-8.50	-19	-79	-37
Consolidated Net Income / (Loss)	7.72	44	7.32	-8.76	-2.48	-45	-1.77	-8.50	-19	-79	-37
Depreciation Expense	2.84	2.53	3.57	1.51	1.73	1.18	2.15	2.38	2.41	2.62	3.45
Non-Cash Adjustments To Reconcile Net Income	1.88	-45	-3.13	12	5.25	43	-4.26	2.10	9.06	29	20
Changes in Operating Assets and Liabilities, net	-15	5.98	3.82	-3.41	-6.70	17	3.70	-7.76	-40	23	-0.05
Net Cash From Investing Activities	-55	-5.03	-0.82	-8.56	190	82	158	4.85	-304	158	-120
Net Cash From Continuing Investing Activities	-55	-5.03	-0.82	-8.56	190	82	158	4.85	-304	158	-120
Purchase of Property, Plant & Equipment	-15	-3.54	-6.42	-0.73	-1.72	-1.22	0.01	-0.49	-0.80	-0.36	-0.87
Acquisitions	-0.10	-0.17	-0.12	-0.19	-0.27	-0.57	-0.34	-0.01	0.00	-0.40	-0.76
Purchase of Investments	-40	-	-	-	0.00	-71	-57	-57	-423	3.99	-118
Sale and/or Maturity of Investments	0.00	-1.35	-0.28	-1.43	189	152	211	57	113	152	-1.05
Other Investing Activities, net	0.00	0.03	0.01	-6.22	2.68	2.68	3.97	5.14	6.25	3.29	0.77
Net Cash From Financing Activities	-2.93	-0.31	-0.01	-0.26	-0.65	-0.22	-0.03	-0.04	-0.74	-0.62	-0.24
Net Cash From Continuing Financing Activities	-2.93	-0.31	-0.01	-0.26	-0.65	-0.22	-0.03	-0.04	-0.74	-0.62	-0.24
Other Financing Activities, net	-2.93	-0.31	-0.01	-0.26	-0.65	-0.22	-0.03	-0.04	-0.74	-0.62	-0.13
Effect of Exchange Rate Changes	-0.60	-5.60	3.09	0.15	-0.88	-0.86	4.87	2.73	1.27	-2.12	-23
Cash Interest Paid	0.00	-	-	-	0.00	-	-	-	0.00	-	-
Cash Interest Received	13	9.43	11	14	15	14	8.82	5.83	7.56	7.81	4.24
Cash Income Taxes Paid	0.05	0.03	0.01	0.04	0.58	-	0.02	0.06	33	0.02	0.02

This table presents Cronos Group's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Total Assets	1,166	1,140	1,213
Total Current Assets	936	933	960
Cash & Equivalents	859	669	765
Short-Term Investments	0.00	192	113
Note & Lease Receivable	9.31	16	11
Accounts Receivable	20	20	26
Inventories, net	33	30	38
Prepaid Expenses	6.28	5.41	7.11
Other Current Assets	8.11	0.00	-
Plant, Property, & Equipment, net	133	59	61
Total Noncurrent Assets	97	147	192
Long-Term Investments	2.81	55	90
Noncurrent Note & Lease Receivables	16	69	72
Goodwill	63	1.06	1.03
Intangible Assets	11	21	27
Noncurrent Deferred & Refundable Income Taxes	2.57	0.23	-
Other Noncurrent Operating Assets	1.39	1.36	2.47
Total Liabilities & Shareholders' Equity	1,166	1,140	1,213
Total Liabilities	55	44	72
Total Current Liabilities	50	41	68
Accounts Payable	17	12	11
Accrued Expenses	32	28	22
Current Deferred & Payable Income Tax Liabilities	0.01	0.06	33
Other Current Liabilities	1.07	1.47	1.73
Total Noncurrent Liabilities	5.63	2.74	3.93
Noncurrent Deferred & Payable Income Tax Liabilities	3.56	0.18	-
Other Noncurrent Operating Liabilities	2.07	2.56	3.93
Total Equity & Noncontrolling Interests	1,111	1,096	1,141
Total Preferred & Common Equity	1,064	1,100	1,144
Total Common Equity	1,064	1,100	1,144
Common Stock	670	662	654
Retained Earnings	458	417	491
Accumulated Other Comprehensive Income / (Loss)	-64	21	-0.80
Noncontrolling Interest	47	-3.45	-2.92

This table presents Cronos Group's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	1,154	1,184	1,091	1,109	1,150	1,168	1,160	1,237
Total Current Assets	919	959	935	942	918	925	916	963
Cash & Equivalents	798	862	848	855	572	409	414	633
Short-Term Investments	40	0.00	0.00	0.00	268	432	423	255
Note & Lease Receivable	5.69	7.42	10	9.53	17	14	5.57	8.74
Accounts Receivable	26	26	23	21	20	17	22	23
Inventories, net	35	47	29	31	36	45	44	34
Prepaid Expenses	6.31	7.33	5.25	6.28	5.66	6.78	7.97	8.90
Other Current Assets	8.09	8.97	19	19	-	-	-	-
Plant, Property, & Equipment, net	139	163	37	37	56	58	60	61
Total Noncurrent Assets	96	62	119	129	176	186	184	214
Long-Term Investments	2.76	2.90	24	40	80	86	81	114
Noncurrent Note & Lease Receivables	16	16	73	67	68	71	72	72
Goodwill	63	38	1.02	1.04	1.03	1.06	1.04	1.01
Intangible Assets	11	4.25	19	20	24	25	26	21
Noncurrent Deferred & Refundable Income Taxes	2.51	-	-	-	0.74	1.14	-	-
Other Noncurrent Operating Assets	1.32	1.18	1.12	1.27	1.42	1.57	3.52	5.27
Total Liabilities & Shareholders' Equity	1,154	1,184	1,091	1,109	1,150	1,168	1,160	1,237
Total Liabilities	39	53	35	36	33	32	33	46
Total Current Liabilities	33	40	33	33	31	28	29	38
Accounts Payable	9.50	6.53	7.84	9.40	4.75	9.34	13	10
Accrued Expenses	23	32	24	23	24	17	14	26
Current Deferred & Payable Income Tax Liabilities	0.01	0.09	0.06	0.07	0.64	0.44	0.27	-
Other Current Liabilities	0.99	1.17	1.31	1.44	1.33	1.58	1.32	1.97
Total Noncurrent Liabilities	6.01	13	2.20	2.34	2.76	3.75	4.04	8.26
Noncurrent Deferred & Payable Income Tax Liabilities	4.56	11	-	-	-	0.68	0.38	1.92
Other Noncurrent Operating Liabilities	1.45	2.12	2.20	2.34	2.76	3.07	2.30	4.99
Total Equity & Noncontrolling Interests	1,115	1,131	1,056	1,073	1,117	1,137	1,126	1,191
Total Preferred & Common Equity	1,066	1,082	1,059	1,076	1,120	1,140	1,129	1,194
Total Common Equity	1,066	1,082	1,059	1,076	1,120	1,140	1,129	1,194
Common Stock	669	668	666	664	660	658	656	644
Retained Earnings	464	414	406	414	462	463	472	570
Accumulated Other Comprehensive Income / (Loss)	-66	-0.36	-12	-1.79	-2.11	18	1.54	-19
Noncontrolling Interest	48	50	-3.52	-3.58	-3.06	-3.02	-2.93	-2.91

This table displays calculated financial ratios and metrics derived from Cronos Group's official financial filings.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Growth Metrics	-	-	-
Revenue Growth	34.82%	0.57%	34.37%
EBITDA Growth	65.42%	11.33%	-15.23%
EBIT Growth	60.26%	13.74%	-11.71%
NOPAT Growth	-41.03%	23.90%	61.84%
Net Income Growth	153.68%	55.82%	57.52%
EPS Growth	157.89%	57.78%	57.94%
Operating Cash Flow Growth	143.99%	51.84%	42.10%
Free Cash Flow Firm Growth	-133.14%	-19.24%	-9,641.04%
Invested Capital Growth	38.65%	3.67%	-11.65%
Revenue Q/Q Growth	-4.81%	5.07%	-19.60%
EBITDA Q/Q Growth	70.09%	-12.89%	-787.55%
EBIT Q/Q Growth	65.29%	-10.55%	-6,139.17%
NOPAT Q/Q Growth	-37.78%	1.29%	55.66%
Net Income Q/Q Growth	181.77%	31.21%	24.59%
EPS Q/Q Growth	184.62%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	-32.55%	49.02%	11.51%
Free Cash Flow Firm Q/Q Growth	-17.56%	1.76%	28.35%
Invested Capital Q/Q Growth	-6.39%	-8.61%	-8.71%
Profitability Metrics	-	-	-
Gross Margin	21.42%	13.65%	17.79%
EBITDA Margin	-34.80%	-135.69%	-153.90%
Operating Margin	-65.07%	-97.20%	-128.45%
EBIT Margin	-42.74%	-144.99%	-169.03%
Profit (Net Income) Margin	34.03%	-85.46%	-194.51%
Tax Burden Percent	109.39%	101.20%	139.45%
Interest Burden Percent	-72.78%	58.24%	82.52%
Effective Tax Rate	-9.39%	0.00%	0.00%
Return on Invested Capital (ROIC)	-39.01%	-33.60%	-42.18%
ROIC Less NNEP Spread (ROIC-NNEP)	-52.93%	-31.99%	-33.56%
Return on Net Nonoperating Assets (RNNOA)	42.64%	26.93%	28.54%
Return on Equity (ROE)	3.63%	-6.67%	-13.63%
Cash Return on Invested Capital (CROIC)	-71.40%	-37.20%	-29.80%
Operating Return on Assets (OROA)	-4.36%	-10.75%	-11.23%
Return on Assets (ROA)	3.47%	-6.34%	-12.93%
Return on Common Equity (ROCE)	3.56%	-6.68%	-13.67%
Return on Equity Simple (ROE_SIMPLE)	3.76%	-6.78%	-14.75%
Net Operating Profit after Tax (NOPAT)	-84	-59	-78
NOPAT Margin	-71.18%	-68.04%	-89.91%
Net Nonoperating Expense Percent (NNEP)	13.92%	-1.61%	-8.62%
Return On Investment Capital (ROIC_SIMPLE)	-7.54%	-5.42%	-6.84%
Cost of Revenue to Revenue	78.58%	86.35%	82.21%
SG&A Expenses to Revenue	39.55%	56.71%	78.01%
R&D to Revenue	3.60%	6.70%	15.14%
Operating Expenses to Revenue	86.49%	110.85%	146.24%
Earnings before Interest and Taxes (EBIT)	-50	-126	-147
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-41	-118	-134
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	0.73	0.72	0.84
Price to Tangible Book Value (P/TBV)	0.78	0.74	0.86
Price to Revenue (P/Rev)	6.57	9.13	11.08
Price to Earnings (P/E)	18.80	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	5.32%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00
Leverage & Solvency	-	-	-
Debt to Equity	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00
Financial Leverage	-0.81	-0.84	-0.85
Leverage Ratio	1.05	1.05	1.05
Compound Leverage Factor	-0.76	0.61	0.87
Debt to Total Capital	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	4.22%	-0.31%	-0.26%
Common Equity to Total Capital	95.78%	100.31%	100.26%
Debt to EBITDA	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00
Altman Z-Score	9.79	11.99	9.13
Noncontrolling Interest Sharing Ratio	1.97%	-0.28%	-0.24%
Liquidity Ratios	-	-	-
Current Ratio	18.84	22.54	14.10
Quick Ratio	17.88	21.68	13.44
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	-153	-66	-55
Operating Cash Flow to CapEx	151.83%	-1,709.98%	-2,577.46%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00
Efficiency Ratios	-	-	-
Asset Turnover	0.10	0.07	0.07
Accounts Receivable Turnover	5.77	3.73	3.20
Inventory Turnover	2.90	2.21	2.03
Fixed Asset Turnover	1.22	1.45	1.29
Accounts Payable Turnover	6.35	6.47	6.28
Days Sales Outstanding (DSO)	63.29	97.77	114.11
Days Inventory Outstanding (DIO)	125.68	164.87	180.06
Days Payable Outstanding (DPO)	57.47	56.43	58.12
Cash Conversion Cycle (CCC)	131.50	206.21	236.06
Capital & Investment Metrics	-	-	-
Invested Capital	249	180	173
Invested Capital Turnover	0.55	0.49	0.47
Increase / (Decrease) in Invested Capital	70	6.36	-23
Enterprise Value (EV)	-42	-123	-9.08
Market Capitalization	772	797	961
Book Value per Share	$2.78	$2.89	$3.02
Tangible Book Value per Share	$2.59	$2.83	$2.95
Total Capital	1,111	1,096	1,141
Total Debt	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00
Net Debt	-862	-916	-967
Capital Expenditures (CapEx)	12	2.51	3.45
Debt-free, Cash-free Net Working Capital (DFCFNWC)	28	30	14
Debt-free Net Working Capital (DFNWC)	886	892	892
Net Working Capital (NWC)	886	892	892
Net Nonoperating Expense (NNE)	-124	15	91
Net Nonoperating Obligations (NNO)	-862	-916	-967
Total Depreciation and Amortization (D&A)	9.34	8.11	13
Debt-free, Cash-free Net Working Capital to Revenue	23.47%	34.82%	16.51%
Debt-free Net Working Capital to Revenue	753.66%	1,022.35%	1,028.30%
Net Working Capital to Revenue	753.66%	1,022.35%	1,028.30%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	$0.11	($0.19)	$0.00
Adjusted Weighted Average Basic Shares Outstanding	382.53M	381.30M	380.58M
Adjusted Diluted Earnings per Share	$0.11	($0.19)	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	382.53M	381.30M	380.58M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	382.53M	381.30M	380.58M
Normalized Net Operating Profit after Tax (NOPAT)	-42	-56	-73
Normalized NOPAT Margin	-35.44%	-64.12%	-84.24%
Pre Tax Income Margin	31.11%	-84.44%	-139.49%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Cronos Group's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	27.58%	-24.85%	87.80%	45.95%	29.72%	21.37%	21.56%	-11.95%	-22.12%	23.77%	0.01%
EBITDA Growth	102.61%	161.73%	-142.90%	-46.80%	38.71%	-29.51%	55.01%	28.24%	11.96%	-112.19%	-141.79%
EBIT Growth	87.21%	156.36%	-133.35%	-36.14%	37.86%	-24.92%	53.40%	30.67%	12.19%	-113.11%	-148.38%
NOPAT Growth	61.24%	28.23%	-250.33%	24.53%	23.21%	4.87%	20.34%	18.50%	42.39%	-114.99%	66.15%
Net Income Growth	410.91%	197.59%	513.32%	-3.08%	87.10%	42.90%	95.20%	58.22%	41.03%	41.10%	-147.49%
EPS Growth	300.00%	200.00%	0.00%	0.00%	80.00%	0.00%	100.00%	60.00%	0.00%	0.00%	0.00%
Operating Cash Flow Growth	4.90%	-54.09%	6,429.51%	114.81%	95.38%	168.99%	98.63%	31.86%	-40.64%	32.18%	57.48%
Free Cash Flow Firm Growth	-567.23%	-273.72%	-458.80%	218.33%	283.65%	-408.97%	-127.55%	77.90%	-116.01%	-97.76%	-21.71%
Invested Capital Growth	54.57%	38.65%	35.35%	-12.83%	-15.61%	3.67%	3.56%	-0.41%	-1.29%	-11.65%	-34.25%
Revenue Q/Q Growth	79.52%	-61.43%	67.83%	9.78%	8.69%	-3.61%	30.43%	-2.43%	-1.07%	-3.45%	-5.52%
EBITDA Q/Q Growth	-98.79%	199.62%	-54.47%	-39.90%	70.72%	-291.99%	6.64%	41.60%	39.41%	-36.16%	-48.93%
EBIT Q/Q Growth	-107.03%	184.54%	-59.33%	-35.05%	68.38%	-250.06%	7.04%	38.36%	37.72%	-30.57%	-38.31%
NOPAT Q/Q Growth	60.19%	79.65%	-390.23%	2.43%	21.86%	0.64%	-5.60%	0.72%	8.68%	16.80%	-8.03%
Net Income Q/Q Growth	-82.42%	499.96%	183.62%	-252.62%	94.48%	-2,441.03%	79.15%	55.88%	75.58%	-113.79%	-81.36%
EPS Q/Q Growth	-83.33%	500.00%	200.00%	-100.00%	0.00%	0.00%	100.00%	60.00%	0.00%	0.00%	-100.00%
Operating Cash Flow Q/Q Growth	-127.15%	-33.35%	564.16%	179.13%	-113.11%	9,288.52%	98.45%	75.31%	-95.69%	-82.08%	22.54%
Free Cash Flow Firm Q/Q Growth	-25.82%	34.64%	-865.60%	-25.79%	204.83%	2.27%	-62.12%	-15.17%	-269.32%	-91.28%	230.02%
Invested Capital Q/Q Growth	9.96%	-6.39%	45.40%	3.28%	-1.37%	-8.61%	-6.36%	-0.01%	21.15%	-8.71%	-9.94%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	42.57%	60.14%	7.75%	22.68%	17.73%	8.00%	16.00%	16.29%	15.01%	5.30%	15.41%
EBITDA Margin	1.37%	203.70%	-78.86%	-85.69%	-67.24%	-247.96%	-60.98%	-85.19%	-142.32%	-232.37%	-164.77%
Operating Margin	-12.62%	-63.24%	-72.23%	-56.05%	-63.07%	-90.47%	-87.77%	-108.41%	-106.54%	-115.42%	-133.93%
EBIT Margin	-7.43%	189.65%	-86.52%	-91.14%	-74.09%	-252.88%	-69.63%	-97.70%	-154.66%	-245.68%	-181.67%
Profit (Net Income) Margin	23.94%	244.51%	15.72%	-31.55%	-9.82%	-188.28%	-7.14%	-44.67%	-98.78%	-400.19%	-180.73%
Tax Burden Percent	106.26%	95.64%	158.67%	80.12%	81.66%	98.94%	62.31%	145.42%	98.90%	197.69%	119.04%
Interest Burden Percent	-303.21%	134.81%	-11.45%	43.21%	16.24%	75.25%	16.46%	31.44%	64.58%	82.40%	83.58%
Effective Tax Rate	-6.26%	4.36%	-58.67%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-7.40%	-33.15%	-61.14%	-20.30%	-21.19%	-31.27%	-26.37%	-28.33%	-28.63%	-37.90%	-42.23%
ROIC Less NNEP Spread (ROIC-NNEP)	-8.79%	-39.31%	-67.95%	-20.54%	-22.15%	-28.10%	-27.78%	-28.93%	-28.16%	-31.92%	-40.59%
Return on Net Nonoperating Assets (RNNOA)	6.97%	31.67%	53.95%	16.85%	18.25%	23.66%	23.12%	23.90%	23.29%	27.15%	33.24%
Return on Equity (ROE)	-0.43%	-1.48%	-7.20%	-3.45%	-2.95%	-7.61%	-3.25%	-4.44%	-5.33%	-10.75%	-8.98%
Cash Return on Invested Capital (CROIC)	-73.54%	-71.40%	-56.28%	-12.96%	-11.96%	-37.20%	-34.59%	-29.99%	-30.51%	-29.80%	-32.11%
Operating Return on Assets (OROA)	-0.82%	19.34%	-9.16%	-8.21%	-6.08%	-18.75%	-4.84%	-6.14%	-9.93%	-16.33%	-14.14%
Return on Assets (ROA)	2.64%	24.94%	1.66%	-2.84%	-0.81%	-13.96%	-0.50%	-2.81%	-6.34%	-26.59%	-14.07%
Return on Common Equity (ROCE)	-0.42%	-1.45%	-7.05%	-3.46%	-2.95%	-7.63%	-3.26%	-4.45%	-5.35%	-10.77%	-9.00%
Return on Equity Simple (ROE_SIMPLE)	4.71%	0.00%	-4.53%	-5.48%	-5.37%	0.00%	-9.68%	-12.59%	-13.75%	0.00%	-18.74%
Net Operating Profit after Tax (NOPAT)	-4.33	-11	-53	-11	-11	-15	-15	-14	-15	-16	-19
NOPAT Margin	-13.41%	-60.48%	-114.60%	-39.24%	-44.15%	-63.33%	-61.44%	-75.88%	-74.57%	-80.79%	-93.75%
Net Nonoperating Expense Percent (NNEP)	1.39%	6.17%	6.80%	0.24%	0.96%	-3.17%	1.40%	0.59%	-0.47%	-5.98%	-1.64%
Return On Investment Capital (ROIC_SIMPLE)	-0.39%	-0.98%	-	-	-	-1.38%	-	-	-	-1.40%	-
Cost of Revenue to Revenue	57.43%	39.86%	92.25%	77.32%	82.27%	92.00%	84.00%	83.71%	84.99%	94.70%	84.60%
SG&A Expenses to Revenue	28.85%	67.22%	27.39%	45.99%	35.22%	40.99%	57.90%	70.72%	60.82%	64.28%	80.13%
R&D to Revenue	2.46%	5.72%	2.67%	3.47%	3.94%	6.07%	5.02%	5.82%	10.46%	11.96%	12.45%
Operating Expenses to Revenue	55.19%	123.38%	79.98%	78.73%	80.79%	98.47%	103.77%	124.70%	121.55%	120.72%	149.34%
Earnings before Interest and Taxes (EBIT)	-2.40	34	-40	-25	-19	-60	-17	-19	-30	-48	-37
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	0.44	37	-37	-24	-17	-59	-15	-16	-28	-46	-34
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.65	0.73	0.77	0.84	0.92	0.72	0.68	0.66	0.65	0.84	0.89
Price to Tangible Book Value (P/TBV)	0.70	0.78	0.81	0.86	0.94	0.74	0.70	0.67	0.67	0.86	0.91
Price to Revenue (P/Rev)	5.56	6.57	6.78	8.75	10.70	9.13	9.18	9.54	9.09	11.08	9.88
Price to Earnings (P/E)	14.00	18.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	7.14%	5.32%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.08	0.08	0.54	0.00	0.00	0.00	0.00	0.00	0.32
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.18	0.14	1.03	0.00	0.00	0.00	0.00	0.00	0.56
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.10
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	24.80
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.79	0.86	36.25	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.79	-0.81	-0.79	-0.82	-0.82	-0.84	-0.83	-0.83	-0.83	-0.85	-0.82
Leverage Ratio	1.03	1.05	1.04	1.03	1.03	1.05	1.03	1.03	1.03	1.05	1.05
Compound Leverage Factor	-3.14	1.41	-0.12	0.45	0.17	0.79	0.17	0.32	0.67	0.87	0.88
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	4.34%	4.22%	4.40%	-0.33%	-0.33%	-0.31%	-0.27%	-0.27%	-0.26%	-0.26%	-0.24%
Common Equity to Total Capital	95.66%	95.78%	95.60%	100.33%	100.33%	100.31%	100.27%	100.27%	100.26%	100.26%	100.24%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	12.22	10.03	10.92	16.68	18.23	12.18	15.22	15.70	14.82	9.39	15.36
Noncontrolling Interest Sharing Ratio	2.05%	1.97%	2.08%	-0.30%	-0.30%	-0.28%	-0.26%	-0.25%	-0.25%	-0.24%	-0.22%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	27.80	18.84	24.24	28.29	28.19	22.54	30.03	33.12	31.45	14.10	25.37
Quick Ratio	26.31	17.88	22.64	26.67	26.51	21.68	28.67	31.25	29.66	13.44	24.24
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-101	-80	-123	16	22	-22	-22	-14	-12	6.96	80
Operating Cash Flow to CapEx	-13.74%	217.89%	180.56%	239.23%	-127.84%	1,380.54%	0.00%	-2,383.40%	-5,931.97%	-6,695.60%	-1,540.28%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.11	0.10	0.11	0.09	0.08	0.07	0.07	0.06	0.06	0.07	0.08
Accounts Receivable Turnover	5.27	5.77	5.30	4.99	4.31	3.73	3.84	4.04	3.18	3.20	5.50
Inventory Turnover	2.76	2.90	2.58	2.29	2.12	2.21	2.06	1.61	1.72	2.03	2.78
Fixed Asset Turnover	1.41	1.22	1.13	2.15	1.92	1.45	1.43	1.27	1.23	1.29	0.87
Accounts Payable Turnover	9.54	6.35	19.02	9.91	7.04	6.47	9.52	6.28	5.79	6.28	4.31
Days Sales Outstanding (DSO)	69.32	63.29	68.84	73.13	84.66	97.77	95.11	90.35	114.64	114.11	66.35
Days Inventory Outstanding (DIO)	132.09	125.68	141.39	159.47	171.81	164.87	177.30	226.82	212.70	180.06	131.29
Days Payable Outstanding (DPO)	38.27	57.47	19.20	36.84	51.88	56.43	38.32	58.12	63.09	58.12	84.68
Cash Conversion Cycle (CCC)	163.14	131.50	191.04	195.77	204.59	206.21	234.09	259.06	264.26	236.06	112.96
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	274	249	266	183	177	180	197	210	210	173	190
Invested Capital Turnover	0.55	0.55	0.53	0.52	0.48	0.49	0.43	0.37	0.38	0.47	0.45
Increase / (Decrease) in Invested Capital	97	70	70	-27	-33	6.36	6.76	-0.86	-2.75	-23	-99
Enterprise Value (EV)	-100	-42	22	14	96	-123	-161	-179	-182	-9.08	60
Market Capitalization	692	772	837	890	995	797	762	750	738	961	1,066
Book Value per Share	$2.79	$2.78	$2.83	$2.77	$2.82	$2.89	$2.94	$2.99	$2.97	$3.02	$3.16
Tangible Book Value per Share	$2.59	$2.59	$2.72	$2.72	$2.77	$2.83	$2.87	$2.92	$2.90	$2.95	$3.10
Total Capital	1,115	1,111	1,131	1,056	1,073	1,096	1,117	1,137	1,126	1,141	1,191
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-841	-862	-865	-873	-895	-916	-920	-927	-918	-967	-1,003
Capital Expenditures (CapEx)	15	3.54	6.42	0.73	1.72	1.22	-0.01	0.49	0.80	0.36	0.87
Debt-free, Cash-free Net Working Capital (DFCFNWC)	48	28	58	54	54	30	48	56	51	14	37
Debt-free Net Working Capital (DFNWC)	886	886	920	902	909	892	888	897	887	892	925
Net Working Capital (NWC)	886	886	920	902	909	892	888	897	887	892	925
Net Nonoperating Expense (NNE)	-12	-55	-61	-2.13	-8.68	30	-13	-5.94	4.72	63	18
Net Nonoperating Obligations (NNO)	-841	-862	-865	-873	-895	-916	-920	-927	-916	-967	-1,001
Total Depreciation and Amortization (D&A)	2.84	2.53	3.57	1.51	1.73	1.18	2.15	2.38	2.41	2.62	3.45
Debt-free, Cash-free Net Working Capital to Revenue	38.30%	23.47%	46.60%	53.09%	57.70%	34.82%	58.09%	71.11%	62.28%	16.51%	33.92%
Debt-free Net Working Capital to Revenue	710.76%	753.66%	744.27%	886.49%	976.84%	1,022.35%	1,069.24%	1,140.59%	1,092.23%	1,028.30%	857.67%
Net Working Capital to Revenue	710.76%	753.66%	744.27%	886.49%	976.84%	1,022.35%	1,069.24%	1,140.59%	1,092.23%	1,028.30%	857.67%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.02	$0.12	$0.02	($0.02)	($0.01)	($0.12)	$0.00	($0.02)	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	385.42M	382.53M	382.29M	382.28M	382.01M	381.30M	381.11M	381.09M	380.82M	380.58M	378.47M
Adjusted Diluted Earnings per Share	$0.02	$0.12	$0.02	($0.02)	($0.01)	($0.12)	$0.00	($0.02)	$0.00	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	385.42M	382.53M	382.29M	382.28M	382.01M	381.30M	381.11M	381.09M	380.82M	380.58M	378.47M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	385.42M	382.53M	382.29M	382.28M	382.01M	381.30M	381.11M	381.09M	380.82M	380.58M	378.47M
Normalized Net Operating Profit after Tax (NOPAT)	-2.46	-11	-13	-11	-9.72	-13	-14	-14	-15	-17	-19
Normalized NOPAT Margin	-7.63%	-60.48%	-28.96%	-37.86%	-38.45%	-53.18%	-57.42%	-75.88%	-74.57%	-84.00%	-92.42%
Pre Tax Income Margin	22.53%	255.66%	9.91%	-39.38%	-12.03%	-190.30%	-11.46%	-30.72%	-99.88%	-202.44%	-151.83%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Cronos Group's Financials

When does Cronos Group's financial year end?

According to the most recent income statement we have on file, Cronos Group's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Cronos Group's net income changed over the last 2 years?

Cronos Group's net income appears to be on a downward trend, with a most recent value of $40.02 million in 2024, falling from -$168.73 million in 2022. The previous period was -$74.55 million in 2023.

What is Cronos Group's operating income?

Cronos Group's total operating income in 2024 was -$76.53 million, based on the following breakdown:

Total Gross Profit: $25.20 million
Total Operating Expenses: $101.73 million

How has Cronos Group revenue changed over the last 2 years?

Over the last 2 years, Cronos Group's total revenue changed from $86.75 million in 2022 to $117.62 million in 2024, a change of 35.6%.

How much debt does Cronos Group have?

Cronos Group's total liabilities were at $55.33 million at the end of 2024, a 25.3% increase from 2023, and a 23.2% decrease since 2022.

How much cash does Cronos Group have?

In the past 2 years, Cronos Group's cash and equivalents has ranged from $669.29 million in 2023 to $858.81 million in 2024, and is currently $858.81 million as of their latest financial filing in 2024.

How has Cronos Group's book value per share changed over the last 2 years?

Over the last 2 years, Cronos Group's book value per share changed from 3.02 in 2022 to 2.78 in 2024, a change of -7.9%.

Related Companies

This page (NASDAQ:CRON) was last updated on 5/21/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cronos Group (CRON) Financials

Frequently Asked Questions About Cronos Group's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cronos Group (CRON) Financials

Annual Income Statements for Cronos Group

Quarterly Income Statements for Cronos Group

Annual Cash Flow Statements for Cronos Group

Quarterly Cash Flow Statements for Cronos Group

Annual Balance Sheets for Cronos Group

Quarterly Balance Sheets for Cronos Group

Annual Metrics And Ratios for Cronos Group

Quarterly Metrics And Ratios for Cronos Group

Frequently Asked Questions About Cronos Group's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools